title: WHO issues guidelines on HCV amid drug cost controversy.
authors.forename: Anita
authors.initials: A
authors.lastname: Slomski
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D006526:Hepatitis C / Q000188:drug therapy*; D006575:Heterocyclic Compounds, 3-Ring / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use; D014542:Uridine Monophosphate / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D000998:Antiviral Agents; D006575:Heterocyclic Compounds, 3-Ring; D013449:Sulfonamides; D000069616:Simeprevir; D014542:Uridine Monophosphate; D000069474:Sofosbuvir